TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer

The transient receptor potential melastatin-subfamily member 7 (TRPM7) is a divalent cations permeant channel but also has intrinsic serine/threonine kinase activity. It is ubiquitously expressed in normal tissues and studies have indicated that it participates in important physiological and pharmac...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2021-12, Vol.13 (24), p.6322
Main Authors: Cordier, Clément, Prevarskaya, Natalia, Lehen'kyi, V'yacheslav
Format: Article
Language:English
Subjects:
Breast cancer
Calcium homeostasis
Calcium signalling
Calcium transport
Cell adhesion & migration
Cell cycle
Cell survival
Embryogenesis
Homeostasis
Kinases
Life Sciences
Magnesium
Mammography
Medical prognosis
Mesenchyme
Mortality
Phosphorylation
Physiology
Prognosis
Prostate
Protein-serine/threonine kinase
Proteins
Review
Roles
Therapeutic applications
Therapeutic targets
Transient receptor potential proteins
Tumors
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583
cites cdi_FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583
container_end_page
container_issue 24
container_start_page 6322
container_title Cancers
container_volume 13
creator Cordier, Clément
Prevarskaya, Natalia
Lehen'kyi, V'yacheslav
description The transient receptor potential melastatin-subfamily member 7 (TRPM7) is a divalent cations permeant channel but also has intrinsic serine/threonine kinase activity. It is ubiquitously expressed in normal tissues and studies have indicated that it participates in important physiological and pharmacological processes through its channel-kinase activity, such as calcium/magnesium homeostasis, phosphorylation of proteins involved in embryogenesis or the cellular process. Accumulating evidence has shown that TRPM7 is overexpressed in human pathologies including breast cancer. Breast cancer is the second leading cause of cancer death in women with an incidence rate increase of around 0.5% per year since 2004. The overexpression of TRPM7 may be associated with a poor prognosis in breast cancer patients, so more efforts are needed to research a new therapeutic target. TRPM7 regulates the levels of Ca , which can alter the signaling pathways involved in survival, cell cycle progression, proliferation, growth, migration, invasion, epithelial-mesenchymal transition and thus determines cell behavior, promoting tumor development. This work provides a complete overview of the TRPM7 ion channel and its main involvements in breast cancer. Special consideration is given to the modulation of the channel as a potential target in breast cancer treatment by inhibition of proliferation, migration and invasion. Taken together, these data suggest the potential exploitation of TRPM7 channel-kinase as a therapeutic target and a diagnostic biomarker.
doi_str_mv 10.3390/cancers13246322
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8699295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2614235905</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583</originalsourceid><addsrcrecordid>eNpdkd1LwzAUxYMoKrpn3yTgiz5M0yRNGx8EHX7BZGPM55Cmt67SJTNpBf97U6eiC4GEm3N_OclB6Cgh54xJcmG0NeBDwigXjNIttE9JRodCSL79Z7-HBiG8kjgYSzKR7aI9xiWPk-yjp_ls-pThR2fxaKGtheYST6xxL2Brg2eugYC1LfF8AV6voGtjdepasG2tG1xbfONBhxaPvrwcop1KNwEG3-sBer67nY8ehuPJ_ePoejw0PE3boYa8qExeSJPksiCioJkgVZpGW9LoXAIBKDglppAVI1KTstQ5iLKgouQ8zdkBulpzV12xhNJEO143auXrpfYfyula_T-x9UK9uHeVCympTCPgbA1YbLQ9XI9VXyM8oVTI7D2J2tPvy7x76yC0alkHA02jLbguKCoSTlkqSY892ZC-us7b-BW9imYs47IHXqxVxrsQPFS_DhKi-mTVRrKx4_jve3_1PzmyTz-knq0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612737491</pqid></control><display><type>article</type><title>TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Cordier, Clément ; Prevarskaya, Natalia ; Lehen'kyi, V'yacheslav</creator><creatorcontrib>Cordier, Clément ; Prevarskaya, Natalia ; Lehen'kyi, V'yacheslav</creatorcontrib><description>The transient receptor potential melastatin-subfamily member 7 (TRPM7) is a divalent cations permeant channel but also has intrinsic serine/threonine kinase activity. It is ubiquitously expressed in normal tissues and studies have indicated that it participates in important physiological and pharmacological processes through its channel-kinase activity, such as calcium/magnesium homeostasis, phosphorylation of proteins involved in embryogenesis or the cellular process. Accumulating evidence has shown that TRPM7 is overexpressed in human pathologies including breast cancer. Breast cancer is the second leading cause of cancer death in women with an incidence rate increase of around 0.5% per year since 2004. The overexpression of TRPM7 may be associated with a poor prognosis in breast cancer patients, so more efforts are needed to research a new therapeutic target. TRPM7 regulates the levels of Ca , which can alter the signaling pathways involved in survival, cell cycle progression, proliferation, growth, migration, invasion, epithelial-mesenchymal transition and thus determines cell behavior, promoting tumor development. This work provides a complete overview of the TRPM7 ion channel and its main involvements in breast cancer. Special consideration is given to the modulation of the channel as a potential target in breast cancer treatment by inhibition of proliferation, migration and invasion. Taken together, these data suggest the potential exploitation of TRPM7 channel-kinase as a therapeutic target and a diagnostic biomarker.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13246322</identifier><identifier>PMID: 34944940</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Breast cancer ; Calcium homeostasis ; Calcium signalling ; Calcium transport ; Cell adhesion &amp; migration ; Cell cycle ; Cell survival ; Embryogenesis ; Homeostasis ; Kinases ; Life Sciences ; Magnesium ; Mammography ; Medical prognosis ; Mesenchyme ; Mortality ; Phosphorylation ; Physiology ; Prognosis ; Prostate ; Protein-serine/threonine kinase ; Proteins ; Review ; Roles ; Therapeutic applications ; Therapeutic targets ; Transient receptor potential proteins ; Tumors ; Womens health</subject><ispartof>Cancers, 2021-12, Vol.13 (24), p.6322</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583</citedby><cites>FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583</cites><orcidid>0000-0003-1359-6782 ; 0000-0003-0806-8766</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2612737491/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2612737491?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34944940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04122697$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Cordier, Clément</creatorcontrib><creatorcontrib>Prevarskaya, Natalia</creatorcontrib><creatorcontrib>Lehen'kyi, V'yacheslav</creatorcontrib><title>TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>The transient receptor potential melastatin-subfamily member 7 (TRPM7) is a divalent cations permeant channel but also has intrinsic serine/threonine kinase activity. It is ubiquitously expressed in normal tissues and studies have indicated that it participates in important physiological and pharmacological processes through its channel-kinase activity, such as calcium/magnesium homeostasis, phosphorylation of proteins involved in embryogenesis or the cellular process. Accumulating evidence has shown that TRPM7 is overexpressed in human pathologies including breast cancer. Breast cancer is the second leading cause of cancer death in women with an incidence rate increase of around 0.5% per year since 2004. The overexpression of TRPM7 may be associated with a poor prognosis in breast cancer patients, so more efforts are needed to research a new therapeutic target. TRPM7 regulates the levels of Ca , which can alter the signaling pathways involved in survival, cell cycle progression, proliferation, growth, migration, invasion, epithelial-mesenchymal transition and thus determines cell behavior, promoting tumor development. This work provides a complete overview of the TRPM7 ion channel and its main involvements in breast cancer. Special consideration is given to the modulation of the channel as a potential target in breast cancer treatment by inhibition of proliferation, migration and invasion. Taken together, these data suggest the potential exploitation of TRPM7 channel-kinase as a therapeutic target and a diagnostic biomarker.</description><subject>Breast cancer</subject><subject>Calcium homeostasis</subject><subject>Calcium signalling</subject><subject>Calcium transport</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell cycle</subject><subject>Cell survival</subject><subject>Embryogenesis</subject><subject>Homeostasis</subject><subject>Kinases</subject><subject>Life Sciences</subject><subject>Magnesium</subject><subject>Mammography</subject><subject>Medical prognosis</subject><subject>Mesenchyme</subject><subject>Mortality</subject><subject>Phosphorylation</subject><subject>Physiology</subject><subject>Prognosis</subject><subject>Prostate</subject><subject>Protein-serine/threonine kinase</subject><subject>Proteins</subject><subject>Review</subject><subject>Roles</subject><subject>Therapeutic applications</subject><subject>Therapeutic targets</subject><subject>Transient receptor potential proteins</subject><subject>Tumors</subject><subject>Womens health</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkd1LwzAUxYMoKrpn3yTgiz5M0yRNGx8EHX7BZGPM55Cmt67SJTNpBf97U6eiC4GEm3N_OclB6Cgh54xJcmG0NeBDwigXjNIttE9JRodCSL79Z7-HBiG8kjgYSzKR7aI9xiWPk-yjp_ls-pThR2fxaKGtheYST6xxL2Brg2eugYC1LfF8AV6voGtjdepasG2tG1xbfONBhxaPvrwcop1KNwEG3-sBer67nY8ehuPJ_ePoejw0PE3boYa8qExeSJPksiCioJkgVZpGW9LoXAIBKDglppAVI1KTstQ5iLKgouQ8zdkBulpzV12xhNJEO143auXrpfYfyula_T-x9UK9uHeVCympTCPgbA1YbLQ9XI9VXyM8oVTI7D2J2tPvy7x76yC0alkHA02jLbguKCoSTlkqSY892ZC-us7b-BW9imYs47IHXqxVxrsQPFS_DhKi-mTVRrKx4_jve3_1PzmyTz-knq0</recordid><startdate>20211216</startdate><enddate>20211216</enddate><creator>Cordier, Clément</creator><creator>Prevarskaya, Natalia</creator><creator>Lehen'kyi, V'yacheslav</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1359-6782</orcidid><orcidid>https://orcid.org/0000-0003-0806-8766</orcidid></search><sort><creationdate>20211216</creationdate><title>TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer</title><author>Cordier, Clément ; Prevarskaya, Natalia ; Lehen'kyi, V'yacheslav</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Breast cancer</topic><topic>Calcium homeostasis</topic><topic>Calcium signalling</topic><topic>Calcium transport</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell cycle</topic><topic>Cell survival</topic><topic>Embryogenesis</topic><topic>Homeostasis</topic><topic>Kinases</topic><topic>Life Sciences</topic><topic>Magnesium</topic><topic>Mammography</topic><topic>Medical prognosis</topic><topic>Mesenchyme</topic><topic>Mortality</topic><topic>Phosphorylation</topic><topic>Physiology</topic><topic>Prognosis</topic><topic>Prostate</topic><topic>Protein-serine/threonine kinase</topic><topic>Proteins</topic><topic>Review</topic><topic>Roles</topic><topic>Therapeutic applications</topic><topic>Therapeutic targets</topic><topic>Transient receptor potential proteins</topic><topic>Tumors</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cordier, Clément</creatorcontrib><creatorcontrib>Prevarskaya, Natalia</creatorcontrib><creatorcontrib>Lehen'kyi, V'yacheslav</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cordier, Clément</au><au>Prevarskaya, Natalia</au><au>Lehen'kyi, V'yacheslav</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2021-12-16</date><risdate>2021</risdate><volume>13</volume><issue>24</issue><spage>6322</spage><pages>6322-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>The transient receptor potential melastatin-subfamily member 7 (TRPM7) is a divalent cations permeant channel but also has intrinsic serine/threonine kinase activity. It is ubiquitously expressed in normal tissues and studies have indicated that it participates in important physiological and pharmacological processes through its channel-kinase activity, such as calcium/magnesium homeostasis, phosphorylation of proteins involved in embryogenesis or the cellular process. Accumulating evidence has shown that TRPM7 is overexpressed in human pathologies including breast cancer. Breast cancer is the second leading cause of cancer death in women with an incidence rate increase of around 0.5% per year since 2004. The overexpression of TRPM7 may be associated with a poor prognosis in breast cancer patients, so more efforts are needed to research a new therapeutic target. TRPM7 regulates the levels of Ca , which can alter the signaling pathways involved in survival, cell cycle progression, proliferation, growth, migration, invasion, epithelial-mesenchymal transition and thus determines cell behavior, promoting tumor development. This work provides a complete overview of the TRPM7 ion channel and its main involvements in breast cancer. Special consideration is given to the modulation of the channel as a potential target in breast cancer treatment by inhibition of proliferation, migration and invasion. Taken together, these data suggest the potential exploitation of TRPM7 channel-kinase as a therapeutic target and a diagnostic biomarker.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34944940</pmid><doi>10.3390/cancers13246322</doi><orcidid>https://orcid.org/0000-0003-1359-6782</orcidid><orcidid>https://orcid.org/0000-0003-0806-8766</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2021-12, Vol.13 (24), p.6322
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8699295
source ProQuest - Publicly Available Content Database; PubMed Central
subjects Breast cancer
Calcium homeostasis
Calcium signalling
Calcium transport
Cell adhesion & migration
Cell cycle
Cell survival
Embryogenesis
Homeostasis
Kinases
Life Sciences
Magnesium
Mammography
Medical prognosis
Mesenchyme
Mortality
Phosphorylation
Physiology
Prognosis
Prostate
Protein-serine/threonine kinase
Proteins
Review
Roles
Therapeutic applications
Therapeutic targets
Transient receptor potential proteins
Tumors
Womens health
title TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A53%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TRPM7%20Ion%20Channel:%20Oncogenic%20Roles%20and%20Therapeutic%20Potential%20in%20Breast%20Cancer&rft.jtitle=Cancers&rft.au=Cordier,%20Cl%C3%A9ment&rft.date=2021-12-16&rft.volume=13&rft.issue=24&rft.spage=6322&rft.pages=6322-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13246322&rft_dat=%3Cproquest_pubme%3E2614235905%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-ae8bfc8b9c189b06b2760f553499ca89e0eeb420cb9f309a0dda8e6db26d44583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2612737491&rft_id=info:pmid/34944940&rfr_iscdi=true